St. Paul: Housing, Grand Casino Arena remodel among roundtable topics

posted in: All news | 0

If the Minnesota Legislature doesn’t come through next year with funding for a top-to-bottom renovation of the recently-renamed Grand Casino Arena in downtown St. Paul, what’s the likelihood that the favorite hockey team up and moving to, say, Bloomington?

“We’ve never thought about moving, trying to figure out where else we can go to try and get something done,” said Matt Majka, chief executive officer of the Minnesota Wild, during a live broadcast on Monday from the St. Paul Hotel. “St. Paul is our home. We believe in this city and we’re going to make it happen.”

Majka joined St. Paul Mayor Melvin Carter and representatives of the city council, the St. Paul Downtown Alliance, Securian, Sherman Associates, the St. Paul Saints, the St. Paul Area Chamber and Morrissey Hospitality for an hour-long forum on the future of downtown St. Paul. Moderated by Fox 9 news anchor Randy Meier and broadcast live online by the news station, the forum drew consensus among the group that the capital city’s historic downtown draws thousands of visitors when major events are happening at Grand Casino Arena, Rice Park and Mears Parks, but it struggles to draw outsiders when there aren’t.

“We’re probably as good today as we’ve ever been getting those big events,” said Carter, who said the challenge since the pandemic has become convincing visitors to stick around and enjoy downtown after games and Ordway shows, or when there’s no major spectacle to draw them. “We’re kind of a ‘best kept secret’ city. … We have the Midwest ailment where when we’re excited about something … we make sure no one (hears) about it. We have to break that habit.”

Council President Rebecca Noecker agreed.

“When people visit downtown St. Paul, what I hear them say is ‘charming, historic … and walkable,’” Noecker said. “You can see all the highlights of downtown St. Paul in two hours … but the key is to getting people to want to take that walk.”

Reopening storefronts

Reopening street-level storefronts will be key to restoring vitality downtown, said Richard Dobransky, president of Morrissey Hospitality, which operates the St. Paul Hotel and the St. Paul Grill, as well as catering at the RiverCentre convention center.

“We’re now the host to three different cruise lines who embark or depart from here,” Dobransky said, and those visitors “don’t have a car. They want to walk around this area and spend money, and we don’t really give them a lot of opportunities to spend money. We bus them out to other areas.”

“The street-level retail has got to come back,” he added. “A great example is (Thai and Lao restaurant) Ruam Mit … They are now expanding into the space next door. … We hear from residents, ‘yeah, we go to Ruam Mit twice a week.’ We need more Ruam Mits.”

Downtown Alliance revitalization strategy

Meier largely focused the forum on a downtown revitalization strategy drawn up on behalf of the Downtown Alliance. It calls for attracting 20,000 new residents, 20,000 more workers and increasing visitors by 20%, as well as addressing perceptions of crime and public safety downtown.

“We have not had a problem bringing our employees back downtown when it’s safe,” said Chris Hilger, president and chief executive officer of Securian Financial. “There has been a perception and some reality around downtown safety needs, but I think it’s being addressed.”

Tom Whaley, an executive vice president with the St. Paul Saints, said litter and vandalism create a sense of neglect, which feeds into fear.

“If it’s dirty, if there’s graffiti … when you come in from Woodbury, when you come in from Roseville, it’s how does it look? It’s almost instantaneous,” Whaley said. “We don’t have problems during events. If we start there, I really think that’s clear. It’s how does it look?”

Chris Sherman of real estate development company Sherman Associates said downtown St. Paul is well positioned to transition some of its vacant office buildings into housing. St. Paul has an “atypical” number of “historic buildings that are going to be good candidates for conversion,” said Sherman, who called “live/work/play” branding key to filling empty spaces even when office workers have gone home.

Joe Spencer, president of the Downtown Alliance, noted that the architecture and planning firm Gensler evaluated 20 downtown office buildings and found 50% of them to hold promise as future residences, compared to 30% of the 1,400 buildings the firm had analyzed nationwide.

Arena renovation

Hilger and others agreed that the renovation of the 25-year-old arena is essential for the future of downtown.

Carter and Minnesota Wild owner Craig Leipold asked lawmakers last March for nearly $400 million in state appropriations bonds to fund nearly half of a $769 million renovation of what was then known as the Xcel Energy Center, as well as the adjoining RiverCentre Convention Center and Roy Wilkens Auditorium. With time running out on the legislative session, the two later reduced their late-in-the-session ask, but were unable to draw funding for a scaled-down version of the same project.

“We’ve downsized that project to make it more affordable,” Majka said. “We’ve listened to the feedback we’ve heard from the Legislature. We’ve turned it from a tear-down and complete rebuild of Roy Wilkens (Auditorium), to really a focus on the arena. We’ve taken it down to a $450 million project, with a $50 million request to the state, $200 million mostly from the city and $200 million from the Wild.”

“That’s far less on both a percentage basis and on a real dollars basis than, let’s say, Target Field or U.S. Bank Stadium,” Majka added. “But again, I don’t begrudge those, because these are community assets. We all need to maintain these buildings for the good of our communities and cities. We will continue to work with the mayor and his staff, who have been great partners in this effort. And we will find a way to get it done because it must be done for the community and the city’s sake.”

Asked by Meier how quickly that could happen, Majka responded: “As soon as people see the light. And again, I don’t see it as an option that it can’t be renovated. It has to be renovated. These buildings require that. They have to stay up with the times, for HVAC, and cabling, and safety and flow through the arena. It has to change with the times.”

Related Articles


St. Paul: West 7th Street reopened after sinkhole closed area for 4 months


Music and food events abound this weekend in the Twin Cities


MPR political correspondent Clay Masters named new ‘All Things Considered’ host


Farm Aid considering new venue amid Teamsters strike at UMN


Authorities work with boat owner to get beached craft off Harriet Island

My Chemical Romance to bring ‘Black Parade’ tour to Target Field next summer

posted in: All news | 0

Reunited emo rock band My Chemical Romance will play their biggest local show to date when they headline Target Field on Aug. 24.

Tickets go on sale at noon through Ticketmaster. Indie rock veterans Sleater-Kinney open.

Lead singer Gerard Way and drummer Matt Pelissier formed the band in New Jersey shortly after the Sept. 11 attacks. Way said seeing the World Trade Center towers fall made him realize “music was this thing I secretly wanted to do.” Way’s younger brother Mikey joined the group on bass and named them after Irvine Welsh’s novel “Ecstasy: Three Tales of Chemical Romance.”

After releasing their 2002 debut album “I Brought You My Bullets, You Brought Me Your Love” on an independent label, My Chemical Romance signed to Reprise Records. Thanks in large part to heavy touring, the band’s 2004 effort “Three Cheers for Sweet Revenge” went triple platinum, as did its follow-up “The Black Parade.”

My Chemical Romance made “The Black Parade” with Green Day producer Rob Cavallo and took a much more mainstream approach, earning many comparisons to Queen. For their next record, 2010’s “Danger Days: The True Lives of the Fabulous Killjoys,” the band embarked on an arena tour that brought them to the X in September 2011. Two years later, they broke up without citing any specific reasons.

Related Articles


Besides good music, Farm Aid 40 shines a light on Minnesota farmers and politics


Here’s what to know about the new Prince, Replacements and Hüsker Dü reissues


Live Reviews: At Farm Aid 40, an 18-act benefit concert visits MN for the first time


Music and food events abound this weekend in the Twin Cities


Joyce DiDonato is a thrilling partner as Minnesota Orchestra opens season

In 2019, the band announced they were reuniting for what fans thought was a one-off show that December at a Los Angeles theater. It sold out in four minutes and grossed $1.4 million. In January 2020, they revealed a full North American tour that sold out in less than six hours, but it was delayed several times due to the pandemic. The band finally hit the road in 2022 and sold out the venue formerly known as Xcel Energy Center that September.

This summer, My Chemical Romance sold more than 450,000 tickets to their stadium tour of 10 North American markets. As they did at those shows, the band will be playing “The Black Parade” in full during the 2026 tour.

Vikings rookie Donovan Jackson will miss time after having wrist surgery

posted in: All news | 0

After finishing the game for the Vikings on Sunday at U.S. Bank Stadium, rookie left guard Donovan Jackson flew to Los Angeles and underwent successful wrist surgery on Monday.

The announcement from head coach Kevin O’Connell came as a surprise externally because Jackson performed very well for the Vikings in the 48-10 win over the Cincinnati Bengals. It didn’t come as a surprise internally because Jackson actually suffered the injury last week in the 22-6 loss to the Atlanta Falcons.

“It was determined last week that he could play in the football game and not do any further harm,” O’Connell said. “I thought Donovan was fantastic on the field.”

As much as he praised Jackson for the toughness he displayed, O’Connell also made it clear that the Vikings felt it was important that he had wrist surgery so he’d be back to 100 percent sooner rather than later.

“I’m sure he would possibly try to fight through it and worry about everything later,” O’Connell said. “Sometimes we have to do what’s in the best interest of a really talented young player who we have really high aspirations for in the present and in the future.”

This isn’t expected to keep Jackson out long term. In fact, he won’t even be placed on injured reserve, which suggests that the Vikings believe he should be able to return within the next month or so.

As he works his way through the recovery process, Jackson will travel with his teammates across the pond, meaning he will be in attendance when the Vikings play the Pittsburgh Steelers in Dublin and the Cleveland Browns in London.

Though there isn’t a firm timeline as to when he will be back in action, O’Connell mentioned the bye week as a target, meaning Jackson might be ready to roll when the Vikings host the Philadelphia Eagles on Oct. 19.

In the absence of Jackson for at least the next couple of games, the Vikings will turn to veteran left guard Blake Brandel, who has familiarity in that spot, having played there last season.

As soon as Jackson is healthy, he will reassume that role on the starting offensive line.

“He’s off to a great start in his career,” O’Connell said. “Everything we hoped he would be.”

Briefly

After serving his suspension in full, receiver Jordan Addison has officially been reinstated. As a part of the process, the Vikings got a brief roster exemption. They will have to make a corresponding roster move on Wednesday at some point.

Related Articles


Takeaways from the Vikings’ 48-10 win over the Bengals


Shipley: Is it too early for a Vikings quarterback controversy?


Isaiah Rodgers leads Vikings to blowout win over Bengals


The Loop Fantasy Football Update Week 3: Last-minute moves


Harrison Smith and Christian Darrisaw returned for Vikings against Bengals

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

posted in: All news | 0

By TOM MURPHY

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition.

Related Articles


A jury will look at whether Amazon tricked customers into joining Prime — and made it hard to leave


Seattle, a coffee haven, is watching java prices spike. Why?


Spirit Airlines to furlough 1,800 flight attendants amid second bankruptcy


Compass to buy rival brokerage operator Anywhere Real Estate for about $1.5 billion


Nvidia to invest $100 billion in OpenAI to help expand the ChatGPT maker’s computing power

The COVID-19 vaccine and treatment maker said Monday that it will pay $47.50 in cash for each share of development-stage drugmaker Metsera. That represents a premium of more than 42% to Metsera’s closing price Friday.

Pfizer also could pay an additional $22.50 per share depending on how Metsera’s product pipeline develops.

Metsera Inc. has no products on the market, but its pipeline includes four programs in clinical development and one in mid-stage testing. Pfizer said the deal will add expertise and potential oral and injectable treatments.

Pfizer CEO Albert Bourla noted in a statement from the drugmaker that there are more than 200 health conditions associated with obesity, which he called “a large and growing space.”

Demand for obesity treatments has soared in recent years, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Eli Lilly and Co.’s Zepbound. The Lilly drug generated $5.7 billion in sales in the first half of the year.

But the drugs can cost patients hundreds of dollars a month, and experts in the field are looking for competition to potentially drive down prices.

Pfizer currently has no obesity treatments on the market but has some in clinical development. Earlier this year, the company said it was ending development of a potential once-daily pill treatment before it started late-stage testing, the biggest and most expensive phase of clinical development.

Pfizer said the boards of both New York-based companies have approved the deal, but Metsera shareholders still need to OK it. The companies expect the acquisition to close in this year’s fourth quarter. It still needs approval from regulators.

Shares of Pfizer Inc. climbed 38 cents to $24.40 before markets opened Monday while Metsera’s stock advanced about 61%.